Wuxi Biologics (Shanghai) Co. Data, Technology Stack, and Enterprise Applications
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Amazon Web Services (AWS) Legacy Amazon S3 Cloud Storage IaaS n/a 2022 2022
Content Delivery Network IaaS 2022 2022
Content Delivery Network IaaS 2021 2021
IT Decision Makers and Key Stakeholders at Wuxi Biologics (Shanghai) Co.
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Wuxi Biologics (Shanghai) Co. Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Wuxi Biologics (Shanghai) Co. Technographics

Wuxi Biologics (Shanghai) Co. is a Life Sciences organization based in China, with around 1800 employees and annual revenues of $400.0 million.

Wuxi Biologics (Shanghai) Co. operates a diverse technology stack with applications such as Amazon S3 and Hubspot CRM, covering areas like Cloud Storage and CRM.

Wuxi Biologics (Shanghai) Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Amazon Web Services (AWS) and HubSpot.

Wuxi Biologics (Shanghai) Co. recently adopted applications including Amazon S3 in 2022, Cloudflare CDN in 2022 and Eyeota DMP in 2022, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Wuxi Biologics (Shanghai) Co.’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Wuxi Biologics (Shanghai) Co.’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Wuxi Biologics (Shanghai) Co. technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.